[
  {
    "ts": "2026-02-06T13:30:00+00:00",
    "headline": "FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma",
    "summary": "SANTA MONICA, Calif., February 06, 2026--Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous Limitations of Use in patients with relapsed or refractory (R/R) primary central nervous system lymphoma (PCNSL). The updated label reinforces the robust safety data of Yescarta in eligible patients with R/R PCNSL; Yescarta is the only CAR T-cell thera",
    "url": "https://finance.yahoo.com/news/fda-approves-label-kite-yescarta-133000493.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ff89bece-0237-3fa7-b4ab-82e9b44c2ec2",
      "content": {
        "id": "ff89bece-0237-3fa7-b4ab-82e9b44c2ec2",
        "contentType": "STORY",
        "title": "FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma",
        "description": "",
        "summary": "SANTA MONICA, Calif., February 06, 2026--Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous Limitations of Use in patients with relapsed or refractory (R/R) primary central nervous system lymphoma (PCNSL). The updated label reinforces the robust safety data of Yescarta in eligible patients with R/R PCNSL; Yescarta is the only CAR T-cell thera",
        "pubDate": "2026-02-06T13:30:00Z",
        "displayTime": "2026-02-06T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/ab808b3dca0031fe3d8242d0b11384c9",
          "originalWidth": 1595,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1J2SOUWQqXzm0Gt24UEXhQ--~B/aD00ODA7dz0xNTk1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ab808b3dca0031fe3d8242d0b11384c9.cf.webp",
              "width": 1595,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GsB24P7Vc5aUFN26LJDpPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ab808b3dca0031fe3d8242d0b11384c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-label-kite-yescarta-133000493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-label-kite-yescarta-133000493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T16:44:00+00:00",
    "headline": "Is Gilead Sciences (GILD) a 'Buy' Ahead of Its Upcoming Earnings Announcement?",
    "summary": "The company's market-leading HIV franchise has fueled top-line growth.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-gild-buy-ahead-164400408.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "83359206-10f1-3327-bbdb-35a03663827d",
      "content": {
        "id": "83359206-10f1-3327-bbdb-35a03663827d",
        "contentType": "STORY",
        "title": "Is Gilead Sciences (GILD) a 'Buy' Ahead of Its Upcoming Earnings Announcement?",
        "description": "",
        "summary": "The company's market-leading HIV franchise has fueled top-line growth.",
        "pubDate": "2026-02-06T16:44:00Z",
        "displayTime": "2026-02-06T16:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-buy-ahead-164400408.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-buy-ahead-164400408.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T20:50:05+00:00",
    "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "summary": "Health care stocks rose late Friday afternoon, with the NYSE Health Care Index and the State Street",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205005173.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f7d03bf3-26a6-3e0b-ac2d-ba0c44d17991",
      "content": {
        "id": "f7d03bf3-26a6-3e0b-ac2d-ba0c44d17991",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Rise Late Afternoon",
        "description": "",
        "summary": "Health care stocks rose late Friday afternoon, with the NYSE Health Care Index and the State Street",
        "pubDate": "2026-02-06T20:50:05Z",
        "displayTime": "2026-02-06T20:50:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205005173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205005173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "XLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]